WUHAN Achieves A Breakthrough in the Battle Against Covid-19



The ongoing coronavirus disease (COVID-19) outbreak, which emerged in Wuhan, China at the end of 2019, is considered the next big epidemic to cause a huge threat to Global Public Health. On Monday, The country’s health authority said that china has reported 32 new coronavirus cases, including 16 asymptomatic infections.

On Sunday, a total of 16 imported cases were reported as said by the (NHC) National Health Commission. Eleven cases were reported in Sichuan Province, three in Inner Mongolia Autonomous Region, and two in Guangdong Province. Also, the National Health Commission said that there were 16 new asymptomatic cases reported in the country taking the total number of people under medical observation to 397. Moreover, the local health commission said that there is no such asymptomatic case in Wuhan but 320 people are still under quarantine.

Looking in detail, Wuhan is testing its entire 11 million Population for the virus and has found some 200 asymptomatic cases in the past two weeks. However, asymptomatic cases refer to people who are tested COVID-19 positive but develop no symptoms such as cough, sore throat, or fever. Therefore, people with asymptomatic cases will create a problem or danger and a high rise in spreading the coronavirus disease to others.

The NHC (National Health Commission) said that the death toll of coronavirus in china remained at 4634. As of Sunday, the overall confirmed cases had reached 83,017, including 76 patients who were still being treated and 78,307 people who had been discharged after recovery.

As stated by Bloomberg, Wuhan testing blitz in identifying the city’s asymptomatic carriers could allow the city where the virus first emerged to eradicate the pathogen from its population. But its method is likely inaccessible for other countries as it requires the full cooperation of residents and a massive mobilization of resources.

Leave a Reply

Your email address will not be published. Required fields are marked *